Reminiscence, Anxiety and Early Alzheimer's Disease

Withdrawn before enrolling · Not applicable

Conditions studied: Alzheimer's Disease

In brief

This study seeks to establish the acceptability and evaluate the limited efficacy of Simple Reminiscence (SR), a home-delivered non-pharmacological intervention designed to relieve stress, improve affect, and prevent or quell disruptive or maladaptive behaviors in community-residing individuals diagnosed with early Alzheimer's disease (EAD). Unmanaged episodes of anxiety can be antecedents of maladaptive behaviors, including agitation, anger, and sometimes even violence. SR is a dyadic strategy; both the person with EAD and the caregiver engaged the patient's memory to interrupt a current episode of anxiety.

Key facts

Study ID

NCT02319681

Run by

Emory University

People needed

0

Starts

2015-01-01

Expected to finish

2017-06-01

Last updated by the study team

2015-06-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Live in the community
• Reside with a primary caregiver who must be willing to participate in all study activities (the primary caregiver must have a familial or marital relationship with the person with EAD of sufficient length to support reminiscence activity [i.e., an adult child, a long-term spouse or committed partner])
• Have received a diagnosis of Early Alzheimer's Disease from a primary care provider
• Achieve a score on the mini-mental state examination (MMSE) between 19 and 25

You may not qualify if…

• Unable to give consent
• MMSE score lower than 19 or greater than 25.

Where it is running

• Emory Alzheimer's Disease Research Center — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.